The Current Ratio as of December 2025 (TTM) for NeuroScientific Biopharmaceuticals Limited (NSB.AX) is 49.56

According to NeuroScientific Biopharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 49.56. This represents a change of -37.52% compared to the average of 79.32 of the last 4 quarters.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Historical Current Ratio (quarterly & annually)

How has NSB.AX Current Ratio performed in the past?

The mean historical Current Ratio of NeuroScientific Biopharmaceuticals Limited over the last ten years is 30.54. The current 49.56 Current Ratio has changed 16.13% with respect to the historical average. Over the past ten years (40 quarters), NSB.AX's Current Ratio was at its highest in in the December 2018 quarter at 189.37. The Current Ratio was at its lowest in in the December 2016 quarter at 0.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroScientific Biopharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Average Current Ratio

How has NSB.AX Current Ratio performed in the past?

The current Current Ratio of NeuroScientific Biopharmaceuticals Limited (NSB.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Current Ratio vs. Peers

How is NSB.AX’s Current Ratio compared to its peers?

NeuroScientific Biopharmaceuticals Limited’s Current Ratio is greater than Prescient Therapeutics Limited (4.08), greater than Proteomics International Laboratories Limited (9.39), greater than AnteoTech Limited (2.08), greater than Radiopharm Theranostics Limited (2.67), greater than Cynata Therapeutics Limited (4.40), greater than Doctor Care Anywhere Group PLC (1.33), greater than Argenica Therapeutics Limited (2.90), greater than Amplia Therapeutics Limited (7.91), greater than Next Science Limited (1.38), greater than Noxopharm Limited (1.18),

Build a custom stock screener for NeuroScientific Biopharmaceuticals Limited (NSB.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroScientific Biopharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroScientific Biopharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.